Bribery scandal slashes GlaxoSmithKline's Chinese drug sales
LONDON (Reuters) - GlaxoSmithKline's drug sales in China slumped 61 percent in the third quarter, hit by a bribery scandal that damaged its ability to...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/WfpAiYWjZnw/story01.ht
No comments:
Post a Comment